Access the full text.
Sign up today, get DeepDyve free for 14 days.
Aparna Kaul, J. Toonen, P. Cimino, S. Gianino, D. Gutmann (2015)
Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.Neuro-oncology, 17 6
N. Warrington, T. Sun, Jingqin Luo, R. McKinstry, P. Parkin, Sara Ganzhorn, Debra Spoljaric, A. Albers, Amanda Merkelson, D. Stewart, D. Stevenson, D. Viskochil, T. Druley, Jason Forys, Karlyne Reilly, M. Fisher, U. Tabori, J. Allen, J. Schiffman, D. Gutmann, J. Rubin (2015)
The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.Cancer research, 75 1
D. Gutmann (2014)
Eliminating barriers to personalized medicineNeurology, 83
T. Khassawna, D. Toben, Mateusz Kolanczyk, Mateusz Kolanczyk, K. Schmidt-Bleek, I. Koennecke, H. Schell, Stefan Mundlos, Stefan Mundlos, Georg Duda (2012)
Deterioration of fracture healing in the mouse model of NF1 long bone dysplasia.Bone, 51 4
D. Evans, M. Baser, J. McGaughran, S. Sharif, E. Howard, A. Moran (2002)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1Journal of Medical Genetics, 39
K. Cichowski, T. Shih, E. Schmitt, S. Santiago, Karlyne Reilly, M. Mclaughlin, R. Bronson, T. Jacks (1999)
Mouse models of tumor development in neurofibromatosis type 1.Science, 286 5447
Weixi Wang, J. Nyman, K. Ono, D. Stevenson, Xiangli Yang, Florent Elefteriou (2011)
Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.Human molecular genetics, 20 20
Yi-Hsien Chen, L. McGowan, P. Cimino, S. Dahiya, J. Leonard, D. Lee, D. Gutmann (2015)
Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.Cell reports, 10 11
S. Sharif, M. Upadhyaya, R. Ferner, E. Majounie, A. Shenton, M. Baser, N. Thakker, D. Evans (2011)
A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype–phenotype correlationsJournal of Medical Genetics, 48
R. Listernick, R. Ferner, Grant Liu, D. Gutmann (2007)
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendationsAnnals of Neurology, 61
C. Brannan, A. Perkins, K. Vogel, N. Ratner, M. Nordlund, S. Reid, A. Buchberg, N. Jenkins, L. Parada, N. Copeland (1994)
Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.Genes & development, 8 9
Grant Simmons, W. Pong, Ryan Emnett, C. White, S. Gianino, F. Rodriguez, D. Gutmann (2011)
Neurofibromatosis-1 Heterozygosity Increases Microglia in a Spatially and Temporally Restricted Pattern Relevant to Mouse Optic Glioma Formation and GrowthJournal of Neuropathology and Experimental Neurology, 70
J. Nichols, J. Amato, Sophia Chung (2003)
Characteristics of Lisch nodules in patients with neurofibromatosis type 1.Journal of pediatric ophthalmology and strabismus, 40 5
G. Daginakatte, S. Gianino, Nina Zhao, A. Parsadanian, D. Gutmann (2008)
Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.Cancer research, 68 24
J. Guillamo, A. Créange, C. Kalifa, J. Grill, D. Rodriguez, F. Doz, S. Barbarot, M. Zérah, M. Sanson, S. Bastuji‐Garin, P. Wolkenstein (2003)
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.Brain : a journal of neurology, 126 Pt 1
C. Anastasaki, D. Gutmann (2014)
Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.Human molecular genetics, 23 25
Jacquelyn Brown, Ryan Emnett, C. White, Carla Yuede, Sara Conyers, K. O’Malley, D. Wozniak, D. Gutmann (2010)
Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.Human molecular genetics, 19 22
Sheila Llaguno, Jian Chen, C. Kwon, E. Jackson, Yanjiao Li, D. Burns, A. Álvarez-Buylla, L. Parada (2009)
Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.Cancer cell, 15 1
A. Bolčeková, M. Némethová, A. Zaťková, K. Hlinkova, S. Požgayová, A. Hlavatá, L. Kádasi, D. Ďurovčíková, A. Gerinec, K. Husáková, Z. Pavlovicova, M. Holobradá, L. Kovács, D. Ilencikova (2013)
Clustering of mutations in the 5' tertile of the NF1 gene in Slovakia patients with optic pathway glioma.Neoplasma, 60 6
J. Robertson, B. Gunter, G. Somes (2002)
Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee.British Journal of Neurosurgery, 16
R. Ferner, S. Huson, N. Thomas, C. Moss, H. Willshaw, Gareth Evans, M. Upadhyaya, R. Towers, M. Gleeson, Christine Steiger, A. Kirby (2006)
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 44
Michael Fisher, M. Loguidice, D. Gutmann, R. Listernick, R. Ferner, N. Ullrich, R. Packer, U. Tabori, R. Hoffman, S. Ardern–Holmes, T. Hummel, D. Hargrave, E. Bouffet, J. Charrow, L. Bilaniuk, L. Balcer, Lucy McGowan, Grant Liu (2014)
Gender as a disease modifier in neurofibromatosis type 1 optic pathway gliomaAnnals of Neurology, 75
K. Shah (2010)
The diagnostic and clinical significance of café-au-lait macules.Pediatric clinics of North America, 57 5
Ami Patel, D. Eaves, Walter Jessen, T. Rizvi, J. Ecsedy, M. Qian, B. Aronow, J. Perentesis, E. Serra, T. Cripe, Shyra Miller, N. Ratner (2012)
Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic TargetClinical Cancer Research, 18
Xiaohua Wu, S. Estwick, Shi Chen, Menggang Yu, W. Ming, T. Nebesio, Yan Li, Jin Yuan, R. Kapur, D. Ingram, M. Yoder, Feng-Chun Yang (2006)
Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells.Human molecular genetics, 15 19
A. Schindeler, M. Ramachandran, C. Godfrey, A. Morse, M. McDonald, K. Mikulec, D. Little (2008)
Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild‐type and Nf1 haploinsufficient miceJournal of Orthopaedic Research, 26
Andrei Molosh, Philip Johnson, J. Spence, David Arendt, Lauren Federici, C. Bernabé, Steven Janasik, Zaneer Segu, R. Khanna, C. Goswami, Weiguo Zhu, Sujung Park, Lang Li, Y. Mechref, D. Clapp, A. Shekhar (2014)
Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinaseNature neuroscience, 17
Waylan Bessler, Grace Kim, F. Hudson, Julie Mund, R. Mali, Keshav Menon, R. Kapur, D. Clapp, David Ingram, B. Stansfield (2016)
Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.Human molecular genetics, 25 6
CA Stiller, JM Chessells, M. Fitchett (1994)
Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study.British Journal of Cancer, 70
Kara Nunley, Feng Gao, A. Albers, Susan Bayliss, D. Gutmann (2009)
Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.Archives of dermatology, 145 8
Jessica Schaick, Sungjin Kim, K. Broman, Karlyne Reilly (2012)
Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5Mammalian Genome, 23
A. Schindeler, O. Birke, N. Yu, A. Morse, A. Ruys, P. Baldock, D. Little (2011)
Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate.The Journal of bone and joint surgery. British volume, 93 8
Zhiguo Chen, Chiachi Liu, Amish Patel, C. Liao, Yong Wang, L. Le (2014)
Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma.Cancer cell, 26 5
C. Anastasaki, A. Woo, L. Messiaen, D. Gutmann (2015)
Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.Human molecular genetics, 24 12
Yi-Hsien Chen, S. Gianino, D. Gutmann (2015)
Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathwaysGenes & Development, 29
Jean Ndong, Alexander Makowski, S. Uppuganti, G. Vignaux, K. Ono, D. Perrien, S. Joubert, S. Baglio, D. Granchi, D. Stevenson, J. Rios, J. Nyman, Florent Elefteriou (2014)
Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1Nature medicine, 20
G. Johansson, Yonatan Mahller, M. Collins, Mi-Ok Kim, T. Nobukuni, J. Perentesis, T. Cripe, H. Lane, S. Kozma, G. Thomas, N. Ratner (2008)
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumorsMolecular Cancer Therapeutics, 7
Karlyne Reilly, R. Tuskan, Emily Christy, D. Loisel, J. Ledger, R. Bronson, C. Smith, S. Tsang, D. Munroe, T. Jacks (2004)
Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.Proceedings of the National Academy of Sciences of the United States of America, 101 35
D. Jukic (2007)
Association between benign and malignant peripheral nerve sheath tumors in NF1Yearbook of Pathology and Laboratory Medicine, 2007
A. Silva, P. Frankland, Z. Marowitz, E. Friedman, G. Lazlo, Dianna Cioffi, T. Jacks, R. Bourtchuladze (2002)
A mouse model for the learning and memory deficits associated with neurofibromatosis type INature Genetics, 31
A. Watson, L. Anderson, A. Greeley, V. Keng, E. Rahrmann, Amanda Halfond, N. Powell, M. Collins, T. Rizvi, C. Moertel, N. Ratner, D. Largaespada (2014)
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicityOncotarget, 5
B. Hegedűs, Frank Hughes, J. Garbow, S. Gianino, Debasish Banerjee, Keun-Young Kim, Mark Ellisman, M. Brantley, D. Gutmann (2009)
Optic Nerve Dysfunction in a Mouse Model of Neurofibromatosis-1 Optic GliomaJournal of Neuropathology and Experimental Neurology, 68
Kelly Diggs-Andrews, Jacquelyn Brown, S. Gianino, Lucy McGowan, Joshua Rubin, David Wozniak, David Gutmann (2014)
ReplyAnnals of Neurology, 75
Tiffany Chang, Kimberly Krisman, Emily Theobald, Jin Xu, Jon Akutagawa, Jennifer Lauchle, S. Kogan, B. Braun, K. Shannon (2013)
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.The Journal of clinical investigation, 123 1
K. Vogel, K. Vogel, L. Klesse, S. Velasco-Miguel, K. Meyers, E. Rushing, L. Parada (1999)
Mouse tumor model for neurofibromatosis type 1.Science, 286 5447
S. Sharif, R. Ferner, J. Birch, J. Gillespie, H. Gattamaneni, M. Baser, D. Evans (2006)
Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 16
Weidong Li, Yijun Cui, S. Kushner, Robert Brown, J. Jentsch, P. Frankland, Tyrone Cannon, Alcino Silva (2005)
The HMG-CoA Reductase Inhibitor Lovastatin Reverses the Learning and Attention Deficits in a Mouse Model of Neurofibromatosis Type 1Current Biology, 15
S. Hyman, A. Shores, K. North (2005)
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1Neurology, 65
S. Schepper, Ophélia Maertens, T. Callens, J. Naeyaert, J. Lambert, L. Messiaen (2008)
Somatic mutation analysis in NF1 café au lait spots reveals two NF1 hits in the melanocytes.The Journal of investigative dermatology, 128 4
S. Abadin, Nancy Zoellner, Melody Schaeffer, Bree Porcelli, D. Gutmann, Kimberly Johnson (2015)
Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.The Journal of pediatrics, 167 3
B. Hegedűs, Debasish Banerjee, T. Yeh, Stefan Rothermich, A. Perry, J. Rubin, J. Garbow, D. Gutmann (2008)
Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.Cancer research, 68 5
J. Constantino, Yi Zhang, Kieran Holzhauer, Sayli Sant, Kyna Long, Alicia Vallorani, Leena Malik, D. Gutmann (2015)
Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.The Journal of pediatrics, 167 3
N. Warrington, B. Woerner, G. Daginakatte, B. Dasgupta, A. Perry, D. Gutmann, J. Rubin (2007)
Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.Cancer research, 67 18
J. Declue, S. Heffelfinger, G. Benvenuto, B. Ling, S. Li, W. Rui, W. Vass, D. Viskochil, N. Ratner (2000)
Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.The Journal of clinical investigation, 105 9
A. Solga, S. Gianino, D. Gutmann (2014)
NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic gliomaOncogene, 33
D. Lee, T. Yeh, Ryan Emnett, C. White, D. Gutmann (2010)
Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.Genes & development, 24 20
A. Lin, P. Birch, B. Korf, R. Tenconi, M. Niimura, M. Pöyhönen, K. Uhas, M. Sigorini, R. Virdis, C. Romano, E. Bonioli, P. Wolkenstein, E. Pivnick, Marcella Lawrence, J. Friedman (2000)
Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.American journal of medical genetics, 95 2
V. Keng, E. Rahrmann, A. Watson, Barbara Tschida, C. Moertel, Walter Jessen, T. Rizvi, M. Collins, N. Ratner, D. Largaespada (2012)
PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.Cancer research, 72 13
S. Garg, E. Plasschaert, M. Descheemaeker, S. Huson, M. Borghgraef, A. Vogels, D. Evans, E. Legius, Jonathan Green (2015)
Autism Spectrum Disorder Profile in Neurofibromatosis Type IJournal of Autism and Developmental Disorders, 45
A. Tischler, T. Shih, B. Williams, T. Jacks (1995)
Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1Endocrine Pathology, 6
A. Omrani, G. Woerden, Y. Elgersma (2015)
Neurofibromin regulates HCN activity in Parvalbumin-positive interneuronsMolecular Psychiatry, 20
A. Gitler, Y. Kong, J. Choi, Yuan Zhu, W. Pear, J. Epstein (2004)
Tie2-Cre–Induced Inactivation of a Conditional Mutant Nf1 Allele in Mouse Results in a Myeloproliferative Disorder that Models Juvenile Myelomonocytic LeukemiaPediatric Research, 55
Plexiform Neurofibromas, Mpnst (1999)
Plexiform neurofibromas.American journal of medical genetics, 89 1
Jacquelyn Brown, S. Gianino, D. Gutmann (2010)
Defective cAMP Generation Underlies the Sensitivity of CNS Neurons to Neurofibromatosis-1 HeterozygosityThe Journal of Neuroscience, 30
M. Lammert, J. Friedman, L. Kluwe, V. Mautner (2005)
Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.Archives of dermatology, 141 1
Yijun Cui, R. Costa, G. Murphy, Y. Elgersma, Yuan Zhu, D. Gutmann, L. Parada, I. Módy, Alcino Silva (2008)
Neurofibromin Regulation of ERK Signaling Modulates GABA Release and LearningCell, 135
J. Friedman, J. Arbiser, Jonathan Epstein, D. Gutmann, S. Huot, A. Lin, B. McManus, B. Korf (2002)
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task ForceGenetics in Medicine, 4
B. Korf (2000)
Malignancy in neurofibromatosis type 1.The oncologist, 5 6
Yuan Zhu, M. Romero, P. Ghosh, Zhengyi Ye, P. Charnay, Elizabeth Rushing, J. Marth, L. Parada (2001)
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.Genes & development, 15 7
G. Daginakatte, D. Gutmann (2007)
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.Human molecular genetics, 16 9
L. Le, T. Shipman, D. Burns, L. Parada (2009)
Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.Cell stem cell, 4 5
T. Vaart, E. Plasschaert, A. Rietman, M. Renard, R. Oostenbrink, A. Vogels, Marie‐Claire Wit, M. Descheemaeker, Y. Vergouwe, C. Catsman-Berrevoets, E. Legius, Y. Elgersma, H. Moll (2013)
Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trialThe Lancet Neurology, 12
Stephanie Morris, M. Acosta, S. Garg, Jonathan Green, S. Huson, E. Legius, K. North, Jonathan Payne, E. Plasschaert, T. Frazier, L. Weiss, Yi Zhang, D. Gutmann, J. Constantino (2016)
Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).JAMA psychiatry, 73 12
Aparna Kaul, J. Toonen, S. Gianino, D. Gutmann (2015)
The impact of coexisting genetic mutations on murine optic glioma biology.Neuro-oncology, 17 5
K. Rojnueangnit, Jing Xie, A. Gomes, A. Sharp, T. Callens, Yunjia Chen, Y. Liu, M. Cochran, M. Abbott, J. Atkin, D. Babovic‐Vuksanovic, C. Barnett, Melissa Crenshaw, D. Bartholomew, L. Basel, G. Bellus, S. Ben-Shachar, M. Bialer, D. Bick, B. Blumberg, F. Cortés, K. David, A. Destrėe, A. Duat‐Rodríguez, D. Earl, L. Escobar, M. Eswara, B. Ezquieta, I. Frayling, M. Frydman, Kathy Gardner, K. Gripp, C. Hernández‐Chico, K. Heyrman, J. Ibrahim, S. Janssens, B. Keena, I. Llano-Rivas, K. Leppig, M. McDonald, V. Misra, J. Mulbury, V. Narayanan, N. Orenstein, P. Galvin-Parton, Helio Pedro, E. Pivnick, C. Powell, L. Randolph, S. Raskin, J. Rosell, K. Rubin, M. Seashore, C. Schaaf, A. Scheuerle, M. Schultz, E. Schorry, R. Schnur, Elizabeth Siqveland, Amanda Tkachuk, J. Tonsgard, M. Upadhyaya, I. Verma, S. Wallace, C. Williams, E. Zackai, J. Zonana, C. Lázaro, K. Claes, B. Korf, Y. Martín, E. Legius, L. Messiaen (2015)
High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype–Phenotype CorrelationHuman Mutation, 36
L. Lion‐François, F. Gueyffier, C. Mercier, D. Gérard, V. Herbillon, I. Kemlin, D. Rodriguez, T. Ginhoux, E. Peyric, V. Coutinho, V. Bréant, V. Portes, S. Pinson, P. Combemale, B. Kassaï (2014)
The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trialOrphanet Journal of Rare Diseases, 9
Feng-Chun Yang, D. Ingram, Shi Chen, Yuan Zhu, Jin Yuan, Xiaohong Li, Xianlin Yang, Scott Knowles, W. Horn, Yan Li, Shaobo Zhang, Yanzhu Yang, S. Vakili, Menggang Yu, D. Burns, K. Robertson, G. Hutchins, L. Parada, D. Clapp (2008)
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1 +/−- and c-kit-Dependent Bone MarrowCell, 135
K. Robertson, G. Nalepa, Feng-Chun Yang, D. Bowers, Chang Ho, Gary Hutchins, J. Croop, T. Vik, S. Denne, L. Parada, C. Hingtgen, L. Walsh, Menggang Yu, K. Pradhan, M. Edwards-Brown, M. Cohen, J. Fletcher, J. Travers, K. Staser, Melissa Lee, Marcie Sherman, Cynthia Davis, Lucy Miller, D. Ingram, D. Clapp (2012)
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.The Lancet. Oncology, 13 12
S. Sharif, A. Moran, S. Huson, R. Iddenden, A. Shenton, E. Howard, D. Evans (2007)
Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screeningJournal of Medical Genetics, 44
J. Toonen, C. Anastasaki, Laura Smithson, S. Gianino, Kairong Li, R. Kesterson, D. Gutmann (2016)
NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.Human molecular genetics, 25 9
I. Pollack, B. Shultz, J. Mulvihill (1996)
The management of brainstem gliomas in patients with neurofibromatosis 1Neurology, 46
Junwang Xu, Fraz Ismat, Tao Wang, Jifu Yang, J. Epstein (2007)
NF1 Regulates a Ras-Dependent Vascular Smooth Muscle Proliferative Injury ResponseCirculation, 116
B. Korf (1992)
Diagnostic outcome in children with multiple café au lait spots.Pediatrics, 90 6
B. Stansfield, Waylan Bessler, R. Mali, Julie Mund, Brandon Downing, R. Kapur, D. Ingram (2014)
Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.The American journal of pathology, 184 1
Yuan Zhu, F. Guignard, Dawen Zhao, Li Liu, D. Burns, R. Mason, A. Messing, L. Parada (2005)
Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.Cancer cell, 8 2
C. Prada, E. Jousma, T. Rizvi, Jianqiang Wu, R. Dunn, Debra Mayes, J. Cancelas, E. Dombi, Mi-Ok Kim, B. West, G. Bollag, N. Ratner (2012)
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibitionActa Neuropathologica, 125
A. Omrani, A. Omrani, T. Vaart, E. Mientjes, G. Woerden, Mohammad Hojjati, Mohammad Hojjati, K. Li, D. Gutmann, C. Levelt, A. Smit, Alcino Silva, S. Kushner, Y. Elgersma (2015)
HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1Molecular Psychiatry, 20
Yuan Zhu, Yuan Zhu, T. Harada, Li Liu, Mark Lush, F. Guignard, C. Harada, D. Burns, M. Bajenaru, D. Gutmann, L. Parada (2005)
Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation, 132
C. Kwon, Dawen Zhao, Jing Chen, S. Alcantara, Yanjiao Li, D. Burns, R. Mason, E. Lee, Hong Wu, L. Parada (2008)
Pten haploinsufficiency accelerates formation of high-grade astrocytomas.Cancer research, 68 9
Kelly Diggs-Andrews, K. Tokuda, Y. Izumi, C. Zorumski, D. Wozniak, D. Gutmann (2013)
Dopamine deficiency underlies learning deficits in neurofibromatosis‐1 miceAnnals of Neurology, 73
Eeva-Mari Jouhilahti, S. Peltonen, T. Callens, E. Jokinen, A. Heape, L. Messiaen, J. Peltonen (2011)
The development of cutaneous neurofibromas.The American journal of pathology, 178 2
G. Bollag, D. Clapp, S. Shih, F. Adler, Youyan Zhang, P. Thompson, B. Lange, M. Freedman, F. McCormick, T. Jacks, K. Shannon (1996)
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cellsNature Genetics, 12
N. Warrington, S. Gianino, Erin Jackson, Patricia Goldhoff, J. Garbow, D. Piwnica-Worms, D. Gutmann, J. Rubin (2010)
Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.Cancer research, 70 14
Amanda Yzaguirre, A. Padmanabhan, Eric Groh, K. Engleka, Jun Li, N. Speck, J. Epstein (2015)
Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryoseLife, 4
Jessica Walrath, K. Fox, E. Truffer, W. Alvord, Octavio Quiñones, Karlyne Reilly (2009)
Chr 19A/J modifies tumor resistance in a sex- and parent-of-origin-specific mannerMammalian Genome, 20
T. Raedt, Eline Beert, E. Pasmant, A. Luscan, H. Brems, N. Ortonne, K. Helin, J. Hornick, V. Mautner, H. Kehrer-Sawatzki, W. Clapp, J. Bradner, M. Vidaud, M. Upadhyaya, E. Legius, K. Cichowski (2014)
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapiesNature, 514
Michael Ferguson, Steven Rhodes, Li Jiang, Xiaohong Li, Jin Yuan, Xianlin Yang, Shaobo Zhang, S. Vakili, P. Territo, G. Hutchins, Feng-Chun Yang, D. Ingram, D. Clapp, Shi Chen (2016)
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform NeurofibromasPediatric Blood & Cancer, 63
W. Pong, Samantha Higer, S. Gianino, Ryan Emnett, D. Gutmann (2013)
Reduced microglial CX3CR1 expression delays neurofibromatosis‐1 glioma formationAnnals of Neurology, 73
Hui-jie Li, Yaling Liu, Qi Zhang, Y. Jing, Shi Chen, Zhaohui Song, Jin-cheng Yan, Yan Li, Xiaohua Wu, Xianghong Zhang, Yingze Zhang, J. Case, Menggang Yu, D. Ingram, Feng-Chun Yang (2009)
Ras Dependent Paracrine Secretion of Osteopontin by Nf1+/− Osteoblasts Promote Osteoclast Activation in a Neurofibromatosis Type I Murine ModelPediatric Research, 65
Sutapa Banerjee, Jonathan Byrd, S. Gianino, Scott Harpstrite, F. Rodriguez, R. Tuskan, Karlyne Reilly, D. Piwnica-Worms, D. Gutmann
Molecular and Cellular Pathobiology the Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity in Vitro and in Vivo
S. Hutter, R. Piro, S. Waszak, H. Kehrer-Sawatzki, R. Friedrich, Á. Lassaletta, O. Witt, J. Korbel, P. Lichter, M. Schuhmann, S. Pfister, U. Tabori, V. Mautner, David Jones (2016)
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patientsHuman Genetics, 135
Feng-Chun Yang, Shi Chen, Travis Clegg, Xiaohong Li, T. Morgan, S. Estwick, Jin Yuan, Waleed Khalaf, Sarah Burgin, J. Travers, L. Parada, D. Ingram, D. Clapp (2006)
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.Human molecular genetics, 15 16
L. Le, Chiachi Liu, T. Shipman, Zhiguo Chen, U. Suter, L. Parada (2011)
Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.Cancer research, 71 13
Yuan Zhu, P. Ghosh, P. Charnay, D. Burns, L. Parada (2002)
Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor EnvironmentScience, 296
R. Friedrich, Claudia Stelljes, C. Hagel, M. Giese, H. Scheuer (2010)
Dysplasia of the orbit and adjacent bone associated with plexiform neurofibroma and ocular disease in 42 NF-1 patients.Anticancer research, 30 5
M. Bajenaru, M. Hernandez, A. Perry, Yuan Zhu, L. Parada, J. Garbow, D. Gutmann (2003)
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.Cancer research, 63 24
K. Vogel, C. Brannan, N. Jenkins, N. Copeland, L. Parada (1995)
Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neuronsCell, 82
Jianqiang Wu, Jon Williams, T. Rizvi, J. Kordich, D. Witte, D. Meijer, A. Stemmer-Rachamimov, J. Cancelas, N. Ratner (2008)
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.Cancer cell, 13 2
R. Listernick, D. Louis, R. Packer, D. Gutmann (1997)
Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the nf1 optic pathway glioma task forceAnnals of Neurology, 41
Laura Smithson, C. Anastasaki, Ran Chen, J. Toonen, Sidney Williams, D. Gutmann (2016)
Contextual signaling in cancer.Seminars in cell & developmental biology, 58
Lianne Krab, Msc Goede-Bolder, F. Aarsen, Ma Saskia, M. Pluijm, Marlies Bouman, Ma Jos, N. Geest, M. Lequin, C. Catsman, Willem Frans, M. Arts, S. Kushner, Alcino Silva, C. Zeeuw, H. Moll, Y. Elgersma
Effect of Simvastatin on Cognitive Functioning in Children with Neurofibromatosis Type 1 a Randomized Controlled Trial
A. Gitler, Yuan Zhu, Fraz Ismat, M. Lu, Yasutaka Yamauchi, L. Parada, J. Epstein (2003)
Nf1 has an essential role in endothelial cellsNature Genetics, 33
A. Solga, W. Pong, Keun-Young Kim, P. Cimino, J. Toonen, Jason Walker, T. Wylie, V. Magrini, M. Griffith, O. Griffith, Amy Ly, Mark Ellisman, E. Mardis, D. Gutmann (2015)
RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma GrowthNeoplasia (New York, N.Y.), 17
D. Lee, S. Gianino, D. Gutmann (2012)
Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.Cancer cell, 22 1
W. Mo, Jian Chen, Amish Patel, Liang Zhang, V. Chau, Yanjiao Li, Woosung Cho, Kyun Lim, Jing Xu, A. Lazar, C. Creighton, Svetlana Bolshakov, R. McKay, D. Lev, L. Le, L. Parada (2013)
CXCR4/CXCL12 Mediate Autocrine Cell- Cycle Progression in NF1-Associated Malignant Peripheral Nerve Sheath TumorsCell, 152
Chong Liu, J. Sage, Michael Miller, R. Verhaak, Simon Hippenmeyer, H. Vogel, O. Foreman, R. Bronson, A. Nishiyama, L. Luo, H. Zong (2011)
Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in GliomaCell, 146
Jennifer Lauchle, Doris Kim, Doan Le, K. Akagi, M. Crone, Kimberly Krisman, K. Warner, J. Bonifas, Qing Li, K. Coakley, E. Diaz-Flores, M. Gorman, S. Przybranowski, Mary Tran, S. Kogan, J. Roose, N. Copeland, N. Jenkins, L. Parada, L. Wolff, J. Sebolt-Leopold, K. Shannon (2009)
Response and Resistance to MEK Inhibition in Leukaemias Initiated by Hyperactive RasNature, 461
(2002)
Neurofibromatosis 1: clinical manifestations and diagnostic criteria
M. Upadhyaya, S. Huson, M. Davies, N. Thomas, N. Chuzhanova, S. Giovannini, D. Evans, E. Howard, B. Kerr, S. Griffiths, C. Consoli, L. Side, Darius Adams, M. Pierpont, R. Hachen, A. Barnicoat, Hua Li, P. Wallace, J. Biervliet, D. Stevenson, D. Viskochil, D. Baralle, E. Haan, V. Riccardi, P. Turnpenny, C. Lázaro, L. Messiaen (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.American journal of human genetics, 80 1
Richa Sharma, Xiaohua Wu, Steven Rhodes, Shi Chen, Yongzheng He, Jin Yuan, Jiliang Li, Xianlin Yang, Xiaohong Li, Li Jiang, Edward Kim, D. Stevenson, D. Viskochil, Mingjiang Xu, Feng-Chun Yang (2013)
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.Human molecular genetics, 22 23
Aparna Kaul, Yi-Hsien Chen, Ryan Emnett, S. Dahiya, D. Gutmann (2012)
Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.Genes & development, 26 23
M. Vlenterie, U. Flucke, L. Hofbauer, H. Timmers, J. Gastmeier, D. Aust, W. Graaf, P. Wesseling, G. Eisenhofer, J. Lenders (2013)
Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I.The American journal of medicine, 126 2
Karlyne Reilly, D. Loisel, R. Bronson, M. Mclaughlin, T. Jacks (2000)
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effectsNature Genetics, 26
I. Matsui, M. Tanimura, N. Kobayashi, T. Sawada, N. Nagahara, J. Akatsuka (1993)
Neurofibromatosis type 1 and childhood cancerCancer, 72
Kelly Diggs-Andrews, Jacquelyn Brown, S. Gianino, J. Rubin, D. Wozniak, D. Gutmann (2014)
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1Annals of Neurology, 75
Walter Jessen, Shyra Miller, E. Jousma, Jianqiang Wu, T. Rizvi, M. Brundage, D. Eaves, B. Widemann, Mi-Ok Kim, E. Dombi, J. Sabo, Atira Dudley, M. Niwa-Kawakita, G. Page, M. Giovannini, B. Aronow, T. Cripe, N. Ratner (2013)
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.The Journal of clinical investigation, 123 1
R. Costa, N. Federov, J. Kogan, G. Murphy, Joel Stern, M. Ohno, R. Kucherlapati, T. Jacks, Alcino Silva (2002)
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1Nature, 415
B. Hegedűs, B. Dasgupta, J. Shin, Ryan Emnett, Elizabeth Hart-Mahon, L. Elghazi, E. Bernal-Mizrachi, D. Gutmann (2007)
Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.Cell stem cell, 1 4
A. Crawford, E. Schorry (1999)
Neurofibromatosis in children: the role of the orthopaedist.The Journal of the American Academy of Orthopaedic Surgeons, 7 4
C. Liao, S. Pradhan, Zhiguo Chen, Amish Patel, R. Booker, L. Le (2016)
The role of nerve microenvironment for neurofibroma developmentOncotarget, 7
Neurofibromatosis type 1 (NF1) is a common neurogenetic disorder in which affected children and adults are predisposed to the development of benign and malignant nervous system tumors. Caused by a germline mutation in the NF1 tumor suppressor gene, individuals with NF1 are prone to optic gliomas, malignant gliomas, neurofibromas, and malignant peripheral nerve sheath tumors, as well as behavioral, cognitive, motor, bone, cardiac, and pigmentary abnormalities. Although NF1 is a classic monogenic syndrome, the clinical features of the disorder and their impact on patient morbidity are variable, even within individuals who bear the same germline NF1 gene mutation. As such, NF1 affords unique opportunities to define the factors that contribute to disease heterogeneity and to develop therapies personalized to a given individual (precision medicine). This review highlights the clinical features of NF1 and the use of genetically engineered mouse models to define the molecular and cellular pathogenesis of NF1-associated nervous system tumors.
Annual Review of Pathology: Mechanisms of Disease – Annual Reviews
Published: Jan 24, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.